Immunic (IMUX) Total Non-Current Liabilities (2013 - 2026)

Immunic has disclosed Total Non-Current Liabilities across 14 years of filings, most recently posting $146000.0 for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $146000.0, down 30.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $146000.0 (down 30.48% YoY), and the FY2025 annual result was $107000.0, down 59.47% from the prior year.
• Total Non-Current Liabilities came in at $146000.0 for Q1 2026 at Immunic, up from $107000.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 million in Q1 2023 to a low of $107000.0 in Q4 2025.
• The 5-year median for Total Non-Current Liabilities is $407000.0 (2022), against an average of $504235.3.
• Across the five-year window, Total Non-Current Liabilities soared 198.28% in 2023 and plunged 80.15% in 2024, its largest moves.
• Immunic's Total Non-Current Liabilities stood at $992000.0 in 2022, then plunged by 35.58% to $639000.0 in 2023, then sank by 58.69% to $264000.0 in 2024, then plunged by 59.47% to $107000.0 in 2025, then soared by 36.45% to $146000.0 in 2026.
• The last three Total Non-Current Liabilities figures came in at $146000.0 (Q1 2026), $107000.0 (Q4 2025), and $126000.0 (Q3 2025), per Business Quant data.